See the DrugPatentWatch profile for ganirelix
What is ganirelix, and what does it do in the body?
Ganirelix is a medication used in fertility treatment to help control how the body releases reproductive hormones. It works by blocking gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland. This blocking action prevents the normal hormonal surges that trigger ovulation. As a result, it helps clinicians better time and manage ovarian stimulation during assisted reproductive technologies like IVF.[1]
How does blocking GnRH change fertility hormone signals?
GnRH normally signals the pituitary to release two key hormones: follicle-stimulating hormone (FSH) and luteinizing hormone (LH). By inhibiting GnRH receptor activity, ganirelix reduces LH release and helps stop the LH surge that would otherwise lead to premature ovulation. That gives fertility specialists more control over follicle development and timing of ovulation triggers.[2]
What is ganirelix used for specifically in fertility care?
Ganirelix is used as part of controlled ovarian stimulation protocols, typically in IVF, to prevent premature LH surges. Clinics use it alongside other injectable fertility medicines (like FSH) to promote multiple mature follicles, then later trigger ovulation at the planned time.[1][2]
How is it different from other fertility injections?
Unlike gonadotropins (such as FSH or LH-containing drugs), which directly add hormones to stimulate the ovaries, ganirelix acts upstream by stopping the pituitary's signaling (via GnRH receptor blockade). This is why it’s often described as an LH surge–preventing “GnRH antagonist.”[1]
Sources
- https://www.drugs.com/ganirelix.html
- https://www.ncbi.nlm.nih.gov/books/